Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia

NCT03711500 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03711500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03711500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Completed
Start date
March 13, 2019
Completion date
April 30, 2021
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizo affective disorder, schizophrenia